Author

Vonn Walter

Pennsylvania State UniversityORCID 0000-0001-6114-6714Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vonn Walter1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Todd D. SchelliD· 2 shared Anirban PauliD· 1 shared Aron E. LukacheriD· 1 shared Arrienne B. ButiciD· 1 shared ChaeMin KimiD· 1 shared Dawit Gebremichael AregawiiD· 1 shared Elia AfanasieviD· 1 shared Elizabeth A. ProctoriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Todd D. SchellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyDOAJ (DOAJ: Directory of Open Access Journals)Peer-reviewedAug 17, 2026

PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation

Arrienne B. Butic, Elia Afanasiev, Samantha A. Spencer…·Aron E. Lukacher

This study shows PD-1 in CD4+ T cells balances antiviral defense and neuroinflammation during polyomavirus CNS infection by modulating CD8+ T cell responses.

DOI 10.1038/s41467-026-76762-3

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 29, 2025

BNIP3-mTOR Signaling Mediates Resistance to MET Inhibition in Glioblastoma

Yunzhan Li, Hanif Khan, Şeyma Demirsoy…·Inan Olmez

This study identifies the BNIP3-mTOR signaling axis as a mediator of resistance to MET inhibition in glioblastoma and shows that combined MET and mTOR inhibition synergistically enhances anti-tumor effects.

DOI 10.64898/2025.12.28.696781

mouseexperimental assay

𝕏 PostBluesky